Dry eye treatment company TearScience, which is considering plans for an initial public stock offering, now has a new chief financial officer.The medical device company has promoted Nicole Wicker from ...
Read more
February 16, 2012 1:09 pm by Chris Seper | 0 Comments
TearScience, the dry eye treatment company fresh off a 510(k) clearance, is starting to explore its options for an initial public offering. But if TearScience does go public, there’s a ...
Read more
February 7, 2012 4:01 pm by Frank Vinluan | 3 Comments
The dry eye treatment developed by TearScience received 510(k) clearance last week, about seven months after the company’s novel medical device received its first marketing go-ahead from the U.S. Food ...
Read more
February 1, 2012 12:35 pm by Frank Vinluan | 0 Comments
Medical device company TearScience has received 510(k) clearance on the latest version of its evaporative dry eye treatment.The Morrisville, North Carolina company’s novel dry eye treatment initially received U.S. Food ...
Read more
October 3, 2011 11:59 am by Frank Vinluan | 0 Comments
Medical device company TearScience has secured $15 million in debt financing that the company will use to support a pair of products addressing evaporative dry eye.The venture debt financing comes ...
Read more
August 16, 2011 10:55 am by Frank Vinluan | 0 Comments
Medical device company TearScience has hired a former Allergan (NYSE:AGN) executive to spearhead European commercialization efforts for its novel dry eye treatment.Deithart Reichardt is now senior vice president of the ...
Read more
A medical device dry-eye treatment that wants to replace eye drops has received U.S. Food and Drug Administration approval.North Carolina’s TearScience has won FDA approval for its LipiFlow Thermal Pulsation ...
Read more
